The Model ORCA-2016CN Clinical Unit is a portable Patient Isolation Unit (PIU) designed to prevent chemical and particulate (biological and radiological) cross-contamination between an enclosed patient and the external environment during evacuation and transport activities. It has been optimized for use in marine environments and for hoisting operations employing the Stokes litter. Use of the ORCA-2016CN allows safe transport of contaminated patients who have been medically stabilized, while protecting boat and cutter crews, aircrews, passengers, auxiliary care providers, and transport assets. The ORCATM Clinical Unit is intended for:

• Isolated transport of medically stabilized patients on aircraft, ambulances, ships, or any vehicle capable of safely transporting a patient on either a Stokes or a NATO standard litter.
• Use with the Stokes litter to hoist and evacuate patients from ships or other marine platforms by rotary wing aircraft.
• Temporary isolation with or without transport of patients within hospitals or other medical facilities.

ORCA™ is a Regulatory Class II Medical device.
It has been cleared by the FDA for marketing in the U.S. and is U.S. Patent Pending
Available on GSA contract GS-07F-037GA

ORCA System Testing

• Pathogen Passage Requirements
• Chemical Agent Permeation
• Aerosol Leakage
• Liquid Penetration
• Comfort Level (Temp./Humidity variants while recording vitals)
• Hoisting operations
• TTP’s completed by U.S. Coast GuardMaterial certified to NFPA 1994-2012 Standard on Protective ensembles for First Responders to CBRN Terrorism Incidents, Class 3.
• Meets the requirements for the resistance of materials used in protective clothing against penetration of blood borne pathogens per ASTM F1671M-13.
• Has been tested and shown to meet and exceed US Military Target Performance Value (TPV) requirements for withstanding permeation by chemical warfare agents (CWA) per the U.S. Army’s Test Operations Procedure (TOP) 8-2-501.